The "Rare Diseases Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The rare diseases treatment market is entering a pivotal phase marked by ...
As Chief Executive Officer of Alexso, Inc., a nationwide pharmaceutical distributor, Farahmand has earned recognition for pairing strategic leadership with compassion at every level of the ...
VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that Dr. Peter Singer, a global ...
The "Forklift Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The forklift market is undergoing rapid transformation, shaped by technology, ...
MURFREESBORO, TN / ACCESS Newswire / December 18, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it has invested $89.2 million, including transaction costs, in four separate ...
Following President Trump's Executive Order, MMJ International Holdings Confirms It Has Final Dose Form, Validated, Reproducible Pharmaceutical Cannabinoid Soft-Gel Capsules Ready for FDA Clinical ...
The "Orphan Drugs Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior leaders in the life sciences face significant transformation in the orphan drugs ...
Neuraworx Medical Technology, Inc., a neurotechnology company developing first-in-class bioelectronic solutions for brain ...
Sermo Barometer reveals shifting access pathways, evolving prescribing behavior, and long-term impacts on patient care.NEW ...
Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and ...
Scholarship winners Angie Guifarro and Jarrett Murphy share their personal stories about how cancer has impacted their lives. DALLAS--(BUSINESS WIRE)--The nationally recognized law firm Baron & Budd ...
Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results